{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-018718","form_type":"8-K","ticker":"MBOT","cik":"0000883975","company_name":"Microbot Medical Inc.","filed_at":"2023-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.594025+00:00","generated_at":"2026-06-14T17:43:27.116513+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Microbot Medical raises $1.4M in registered direct offering of common stock at $2.20/share","bullets":["Sold 655,569 shares of common stock at $2.20/share for gross proceeds of ~$1.44M.","Proceeds to fund LIBERTY Robotic System development, IP expansion, and working capital.","H.C. Wainwright acted as exclusive placement agent; received 7.0% cash fee and 32,778 warrants at $2.75.","Offering closed on May 23, 2023; shares issued under effective shelf registration statement.","Company imposed 5-trading-day restriction on future equity sales after closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-018718","json":"https://secwatch.observer/filing/0001493152-23-018718.json","markdown":"https://secwatch.observer/filing/0001493152-23-018718.md","text":"https://secwatch.observer/filing/0001493152-23-018718.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000149315223018718/0001493152-23-018718-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000149315223018718/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T17:43:27.116513+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6b8fd024a3f6284efb42ef00a5152ef127e56f8e","claim":"Microbot Medical Inc. entered into Engagement Letter with H.C. Wainwright & Co., LLC valued at an aggregate cash fee equal to 7.0% of the gross proceeds (effective 2023-05-16).","evidence_excerpt":"On May 16, 2023 and in connection with the Offering, the Company entered into an engagement letter (the “Engagement Letter”) with H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which Wainwright agreed to serve as the exclusive placement agent for the issuance and sale of securities of the Company pursuant to the Purchase Agreement.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223018718/0001493152-23-018718-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"H.C. Wainwright & Co., LLC"},{"label":"Value","value":"an aggregate cash fee equal to 7.0% of the gross proceeds"},{"label":"Effective","value":"2023-05-16"}],"fact_type":"material_agreement"},{"claim_id":"b3210e368a8a865dc3ff27dfc8f8b3cdc3e1d209","claim":"Microbot Medical Inc. entered into Securities Purchase Agreement with an institutional investor valued at aggregate gross proceeds from the Offering of approximately $1.4 million (effective 2023-05-22).","evidence_excerpt":"On May 22, 2023, Microbot Medical Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”), pursuant to which the Company agreed to issue and sell, in a registered direct offering priced at-the-market under the rules of The Nasdaq Stock Market (the “Offering”), an aggregate of 655,569 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”), at an offering price of $2.20 per share, for aggregate gross proceeds from the Offering of approximately $1.4 million before deducting the placement agent fee (as described in greater detail below) and related offering expenses.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223018718/0001493152-23-018718-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"an institutional investor"},{"label":"Value","value":"aggregate gross proceeds from the Offering of approximately $1.4 million"},{"label":"Effective","value":"2023-05-22"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}